320 related articles for article (PubMed ID: 28963492)
1. Immunoprotective potential of BamA, the outer membrane protein assembly factor, against MDR Acinetobacter baumannii.
Singh R; Capalash N; Sharma P
Sci Rep; 2017 Sep; 7(1):12411. PubMed ID: 28963492
[TBL] [Abstract][Full Text] [Related]
2. Immunoprotective potential of in silico predicted Acinetobacter baumannii outer membrane nuclease, NucAb.
Garg N; Singh R; Shukla G; Capalash N; Sharma P
Int J Med Microbiol; 2016 Jan; 306(1):1-9. PubMed ID: 26614015
[TBL] [Abstract][Full Text] [Related]
3. Immunization with a 22-kDa outer membrane protein elicits protective immunity to multidrug-resistant Acinetobacter baumannii.
Huang W; Yao Y; Wang S; Xia Y; Yang X; Long Q; Sun W; Liu C; Li Y; Chu X; Bai H; Yao Y; Ma Y
Sci Rep; 2016 Feb; 6():20724. PubMed ID: 26853590
[TBL] [Abstract][Full Text] [Related]
4. OmpW is a potential target for eliciting protective immunity against Acinetobacter baumannii infections.
Huang W; Wang S; Yao Y; Xia Y; Yang X; Long Q; Sun W; Liu C; Li Y; Ma Y
Vaccine; 2015 Aug; 33(36):4479-85. PubMed ID: 26207591
[TBL] [Abstract][Full Text] [Related]
5. Intranasal immunization protects against Acinetobacter baumannii-associated pneumonia in mice.
KuoLee R; Harris G; Yan H; Xu HH; Conlan WJ; Patel GB; Chen W
Vaccine; 2015 Jan; 33(1):260-7. PubMed ID: 24699469
[TBL] [Abstract][Full Text] [Related]
6. Evaluationof the New Outer Membrane Protein A Epitope-based Vaccines for Mice Model of Acinetobacter baumannii Associated Pneumonia and Sepsis Infection.
Mehdinejadiani K; Hashemi A; Bandehpour M; Rahmani H; Ranjbar MM; Yardel V; Jalali SA; Mosaffa N
Iran J Allergy Asthma Immunol; 2021 Sep; 20(5):537-549. PubMed ID: 34664813
[TBL] [Abstract][Full Text] [Related]
7. Cross-reactivity and immunotherapeutic potential of BamA recombinant protein from Acinetobacter baumannii.
Vieira de Araujo AE; Conde LV; da Silva Junior HC; de Almeida Machado L; Lara FA; Chapeaurouge A; Pauer H; Pires Hardoim CC; Martha Antunes LC; D'Alincourt Carvalho-Assef AP; Moreno Senna JP
Microbes Infect; 2021; 23(4-5):104801. PubMed ID: 33582283
[TBL] [Abstract][Full Text] [Related]
8. A Multiepitope Peptide, rOmp22, Encapsulated in Chitosan-PLGA Nanoparticles as a Candidate Vaccine Against
Du X; Xue J; Jiang M; Lin S; Huang Y; Deng K; Shu L; Xu H; Li Z; Yao J; Chen S; Shen Z; Feng G
Int J Nanomedicine; 2021; 16():1819-1836. PubMed ID: 33707942
[TBL] [Abstract][Full Text] [Related]
9. Active and passive immunization protects against lethal, extreme drug resistant-Acinetobacter baumannii infection.
Luo G; Lin L; Ibrahim AS; Baquir B; Pantapalangkoor P; Bonomo RA; Doi Y; Adams MD; Russo TA; Spellberg B
PLoS One; 2012; 7(1):e29446. PubMed ID: 22253723
[TBL] [Abstract][Full Text] [Related]
10. An Inactivated Antibiotic-Exposed Whole-Cell Vaccine Enhances Bactericidal Activities Against Multidrug-Resistant Acinetobacter baumannii.
Shu MH; MatRahim N; NorAmdan N; Pang SP; Hashim SH; Phoon WH; AbuBakar S
Sci Rep; 2016 Feb; 6():22332. PubMed ID: 26923424
[TBL] [Abstract][Full Text] [Related]
11. Outer membrane vesicles as an acellular vaccine against Acinetobacter baumannii.
McConnell MJ; Rumbo C; Bou G; Pachón J
Vaccine; 2011 Aug; 29(34):5705-10. PubMed ID: 21679737
[TBL] [Abstract][Full Text] [Related]
12. Vaccination with a live attenuated Acinetobacter baumannii deficient in thioredoxin provides protection against systemic Acinetobacter infection.
Ainsworth S; Ketter PM; Yu JJ; Grimm RC; May HC; Cap AP; Chambers JP; Guentzel MN; Arulanandam BP
Vaccine; 2017 Jun; 35(26):3387-3394. PubMed ID: 28522011
[TBL] [Abstract][Full Text] [Related]
13. Immunization against multidrug-resistant Acinetobacter baumannii effectively protects mice in both pneumonia and sepsis models.
Huang W; Yao Y; Long Q; Yang X; Sun W; Liu C; Jin X; Li Y; Chu X; Chen B; Ma Y
PLoS One; 2014; 9(6):e100727. PubMed ID: 24956279
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of the trimeric autotransporter Ata as a vaccine candidate against Acinetobacter baumannii infections.
Bentancor LV; Routray A; Bozkurt-Guzel C; Camacho-Peiro A; Pier GB; Maira-Litrán T
Infect Immun; 2012 Oct; 80(10):3381-8. PubMed ID: 22825448
[TBL] [Abstract][Full Text] [Related]
15. Mucosal immunization with purified OmpA elicited protective immunity against infections caused by multidrug-resistant Acinetobacter baumannii.
Zhang X; Yang T; Cao J; Sun J; Dai W; Zhang L
Microb Pathog; 2016 Jul; 96():20-5. PubMed ID: 27133268
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of the Protective Efficacy of a Fused OmpK/Omp22 Protein Vaccine Candidate against Acinetobacter baumannii Infection in Mice.
Guo SJ; Ren S; Xie YE
Biomed Environ Sci; 2018 Feb; 31(2):155-158. PubMed ID: 29606195
[TBL] [Abstract][Full Text] [Related]
17. Development of Different Methods for Preparing
Li S; Chen DQ; Ji L; Sun S; Jin Z; Jin ZL; Sun HW; Zeng H; Zhang WJ; Lu DS; Luo P; Zhao AN; Luo J; Zou QM; Li HB
Front Immunol; 2020; 11():1069. PubMed ID: 32655550
[No Abstract] [Full Text] [Related]
18. Employing Escherichia coli-derived outer membrane vesicles as an antigen delivery platform elicits protective immunity against Acinetobacter baumannii infection.
Huang W; Wang S; Yao Y; Xia Y; Yang X; Li K; Sun P; Liu C; Sun W; Bai H; Chu X; Li Y; Ma Y
Sci Rep; 2016 Nov; 6():37242. PubMed ID: 27849050
[TBL] [Abstract][Full Text] [Related]
19. A lethal pneumonia model of Acinetobacter baumannii: an investigation in immunocompetent mice.
Zeng X; Gu H; Cheng Y; Jia KR; Liu D; Yuan Y; Chen ZF; Peng LS; Zou QM; Shi Y
Clin Microbiol Infect; 2019 Apr; 25(4):516.e1-516.e4. PubMed ID: 30583061
[TBL] [Abstract][Full Text] [Related]
20. Exploitation of two siderophore receptors, BauA and BfnH, for protection against Acinetobacter baumannii infection.
Aghajani Z; Rasooli I; Mousavi Gargari SL
APMIS; 2019 Dec; 127(12):753-763. PubMed ID: 31512768
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
